Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 1;134(5):e176938.
doi: 10.1172/JCI176938.

The etiologies of Kawasaki disease

Review

The etiologies of Kawasaki disease

Jane C Burns. J Clin Invest. .

Abstract

Kawasaki disease (KD) is a systemic vasculitis that affects young children and can result in coronary artery aneurysms. The etiology is currently unknown, but new clues from the epidemiology of KD in Japan, the country of highest incidence, are beginning to shed light on what may trigger this acute inflammatory condition. Additional clues from the global changes in KD incidence during the COVID-19 pandemic, coupled with a new birth cohort study from Japan, point to the potential role of person-to-person transmission of an infectious agent. However, the rising incidence of KD in Japan, with coherent waves across the entire country, points to an increasing intensity of exposure that cannot be explained by person-to-person spread. This Review discusses new and historical observations that guide us toward a better understanding of KD etiology and explores hypotheses and interpretations that can provide direction for future investigations. Once the etiology of KD is determined, accurate diagnostic tests will become available, and new, less expensive, and more effective targeted therapies will likely be possible. Clearly, solving the mystery of the etiologies of KD remains a priority for pediatric research.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors have declared that no conflict of interest exists.

Figures

Figure 1
Figure 1. Coronary artery damage from KD.
Illustrations represent giant aneurysms of the right and left anterior descending coronary arteries. IVIG therapy can reduce the prevalence of coronary artery aneurysm following acute KD from 25% to 5%, highlighting the need for accurate diagnostic tests and timely treatment.
Figure 2
Figure 2. Epidemiologic clues from Japan and the United States.
(A) Interpretation of epidemiologic clues from Japan’s unparalleled historical record of KD. Left: The first record of KD-like cases in Japan appeared in the 1950s, following large influxes of people from other regions, including repatriation of Japanese individuals from China and Korea as well as US military occupation following WWII and the Korean War. The subsequent 3 epidemics of KD in 1979, 1982, and 1986 are consistent with the introduction of a causative agent into a highly genetically susceptible population. The plateau period from 1988 to 1992 suggests a steady-state exposure to the KD trigger. Right: The 4.5-fold increase in cases in older children occurring from the mid-1990s to 2019 suggests increasing exposure of large populations to an environmental trigger, possibly a wind-borne aerosol. Post-WWII development or increasing intensity of some human activities could create an aerosol that might amplify this exposure, consistent with the rise in KD cases. Incidence in infants remained essentially unchanged over three decades, suggesting a different mode of exposure to the KD trigger in this youngest age group. In 2020, reduced exposure due to isolation measures taken during the COVID-19 pandemic resulted in a decrease in KD incidence that was mirrored by other countries around the globe. (B) Correlation of the seasonal pattern of KD across prefectures in Japan, 1988–2019. For infants less than 6 months of age (left) there is little coherence in seasonal patterns across Japan, in contrast to children 3 years and older (right), for whom there is striking synchrony of KD seasonal patterns across all of Japan. KD incidence and correlation data were adapted with permission from JAMA Network (16).
Figure 3
Figure 3. Pathways and genes influencing KD susceptibility and outcome.
Figure concept and design are courtesy of Chisato Shimizu.
Figure 4
Figure 4. Suggested research initiatives to shed light on KD etiology.
The figure also depicts the clinical signs of KD.

Similar articles

Cited by

References

    1. McCrindle BW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–e999. doi: 10.1161/CIR.0000000000000484. - DOI - PubMed
    1. Newburger JW, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324(23):1633–1639. doi: 10.1056/NEJM199106063242305. - DOI - PubMed
    1. Tremoulet AH, et al. Increased incidence and severity of Kawasaki disease among Filipino-Americans in San Diego county. Pediatr Infect Dis J. 2011;30(10):909–911. doi: 10.1097/INF.0b013e31821e52c6. - DOI - PubMed
    1. Kushner HI, et al. Kawasaki disease in India: increasing awareness or increased incidence? Perspect Biol Med. 2009;52(1):17–29. doi: 10.1353/pbm.0.0062. - DOI - PubMed
    1. Menon K, et al. Predictors of myocardial ischemia in patients with Kawasaki Disease: insights from patient-specific simulations of coronary hemodynamics. J Cardiovasc Transl Res. 2023;16(5):1099–1109. doi: 10.1007/s12265-023-10374-w. - DOI - PubMed